Intravesical therapy for bladder cancer

Expert Opinion on Pharmacotherapy
Sanjay G PatelGary D Steinberg

Abstract

Transurethral resection of bladder tumor (TURBT) is the gold standard initial diagnostic intervention for bladder cancer and provides diagnostic, therapeutic and prognostic benefit in non-muscle-invasive bladder cancer (NMIBC). However, TURBT alone is inadequate for optimal management of NMIBC, as patients will experience recurrence or progression depending on tumor characteristics. Adjuvant intravesical therapy with either immunotherapy or chemotherapy has been shown to reduce recurrence and/or progression in appropriately selected patients through immunostimulation or direct cell ablation. This review will discuss risk stratification of patients with NMIBC and role of intravesical therapies in reducing recurrence and progression of disease in these patients. A Medline search was performed to identify the best available evidence available from various systematic reviews, meta-analyses, and clinical trials on various immunotherapy and chemotherapy agents. In addition, the main aspects of drug pharmacology (mechanism of action, dosing and administration) and side effects will be reviewed. The selection of the appropriate intravesical agent for NMIBC is complex and is dependent on risk stratification and intravesical agent toxici...Continue Reading

References

Sep 1, 1976·Cancer Treatment Reviews·S T Crooke, W T Bradner
Apr 1, 1992·The Journal of Urology·H W HerrH F Oettgen
Aug 1, 1986·The Journal of Urology·D PodeS Biran
Nov 7, 1980·JAMA : the Journal of the American Medical Association·D Hollister, M Coleman
Jan 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F BoccardoF Selvaggi
Jul 1, 1997·The Journal of Urology·M S CooksonW R Fair
Dec 13, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J MooreN Murray
May 23, 1998·The Journal of Urology·A S BelldegrunR D Williams
Nov 27, 1999·European Urology·P RischmannD K Chopin
Mar 23, 2000·International Journal of Cancer. Journal International Du Cancer·W ZhaoT L Ratliff
Apr 20, 2001·Journal of the National Cancer Institute·J L AuUNKNOWN International Mitomycin C Consortium
Apr 23, 2002·BJU International·J A Martínez-PiñeiroUNKNOWN for CUETO (Club Urológico Español de Tratamiento Oncológico)
May 7, 2002·The Journal of Urology·Nicholas A MaruniakWilliam M Murphy
Aug 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Guido DalbagniDean Bajorin
Feb 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Menachem LauferMerrill J Egorin
May 26, 1955·The New England Journal of Medicine·J C BATEMAN
Oct 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Renzo ColomboMichele Pavone-Macaluso

❮ Previous
Next ❯

Citations

Sep 5, 2015·Journal of medical and biological engineering·Chieh-Hsiao ChenJia-Jin Chen
May 28, 2016·Atherosclerosis·Andrea D van DamJimmy F P Berbée
Jan 28, 2017·Nitric Oxide : Biology and Chemistry·Barbara Prack Mc CormickAna María Eiján
Aug 23, 2019·Nature Reviews. Urology·Gregory A JoiceMax Kates
Feb 24, 2017·Journal of Biosciences·Daiane Teixeira DE OliveiraGlenda Nicioli DA Silva

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.